Pharmacistcoop - DOACs
Replacing warfarin with a NOAC in patients on chronic anticoagulation therapy - The Hospitalist
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial - The Lancet Haematology
Rivaroxaban: a fully-subsidised oral anticoagulant
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Current status of oral anticoagulant adherence in Japanese patients with atrial fibrillation: A claims database analysis - Journal of Cardiology
Oral Anticoagulation Management Cheat Sheet: Warfarin, ... | GrepMed
The market for oral anticoagulants | Nature Reviews Drug Discovery
Moving towards ideal and appropriate models of anticoagulation management service Raphael A - Ann Afr Med
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic - Thrombosis Research
Switching between anticoagulant regimes; *half dose for edoxaban;... | Download Scientific Diagram
Guidance on use of Direct Oral Anti-Coagulants (DOACs) and warfarin in non- valvular Atrial Fibrillation Contents
Switching between anticoagulant regimes; *half dose for edoxaban;... | Download Scientific Diagram
![PDF] When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f01cfb003b76789c5e1bc7cb09440d38d98a84b1/5-Table1-1.png "PDF] When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics | Semantic Scholar")
PDF] When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics | Semantic Scholar
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis - ScienceDirect
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
DOACs: Oral Anticoagulant Treatment of Choice for Pulmonary Embolism? - Endovascular Today
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide | SpringerLink
Anticoagulant Comparison Chart
T1.medium.gif
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
JCM | Free Full-Text | Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants | HTML
